CIBC World Market’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.67M | Sell |
33,360
-241
| -0.7% | -$19.9K | ﹤0.01% | 699 |
|
|
2025
Q4 | $2.86M | Buy |
33,601
+9,120
| +37% | +$748K | ﹤0.01% | 695 |
|
|
2025
Q3 | $1.9M | Buy |
24,481
+1,695
| +7% | +$132K | ﹤0.01% | 806 |
|
|
2025
Q2 | $1.78M | Sell |
22,786
-1,546
| -6% | -$115K | ﹤0.01% | 767 |
|
|
2025
Q1 | $1.76M | Sell |
24,332
-1,189
| -5% | -$85.1K | ﹤0.01% | 747 |
|
|
2024
Q4 | $1.89M | Buy |
25,521
+10,935
| +75% | +$765K | ﹤0.01% | 736 |
|
|
2024
Q3 | $963K | Sell |
14,586
-21,736
| -60% | -$1.58M | ﹤0.01% | 840 |
|
|
2024
Q2 | $3.35M | Sell |
36,322
-895
| -2% | -$79.3K | 0.01% | 536 |
|
|
2024
Q1 | $3.56M | Buy |
37,217
+17,453
| +88% | +$1.47M | 0.01% | 529 |
|
|
2023
Q4 | $1.51M | Buy |
19,764
+649
| +3% | +$45.2K | ﹤0.01% | 676 |
|
|
2023
Q3 | $1.32M | Sell |
19,115
-37,776
| -66% | -$3.04M | ﹤0.01% | 670 |
|
|
2023
Q2 | $5.37M | Buy |
56,891
+41,951
| +281% | +$3.65M | 0.02% | 362 |
|
|
2023
Q1 | $1.24M | Buy |
14,940
+696
| +5% | +$54.7K | ﹤0.01% | 702 |
|
|
2022
Q4 | $1.06M | Sell |
14,244
-2,858
| -17% | -$220K | ﹤0.01% | 744 |
|
|
2022
Q3 | $1.41M | Sell |
17,102
-607
| -3% | -$58.4K | 0.01% | 641 |
|
|
2022
Q2 | $1.68M | Sell |
17,709
-25,635
| -59% | -$2.65M | 0.01% | 600 |
|
|
2022
Q1 | $5.1M | Sell |
43,344
-7,964
| -16% | -$893K | 0.02% | 368 |
|
|
2021
Q4 | $6.65M | Sell |
51,308
-30,082
| -37% | -$3.51M | 0.02% | 333 |
|
|
2021
Q3 | $9.21M | Sell |
81,390
-31,141
| -28% | -$3.55M | 0.03% | 254 |
|
|
2021
Q2 | $11.7M | Buy |
112,531
+52,105
| +86% | +$4.91M | 0.03% | 231 |
|
|
2021
Q1 | $5.05M | Buy |
60,426
+224
| +0.4% | +$18.9K | 0.01% | 369 |
|
|
2020
Q4 | $5.49M | Sell |
60,202
-16,764
| -22% | -$1.39M | 0.02% | 340 |
|
|
2020
Q3 | $6.14M | Buy |
76,966
+4,071
| +6% | +$318K | 0.03% | 265 |
|
|
2020
Q2 | $5.04M | Sell |
72,895
-9,320
| -11% | -$662K | 0.02% | 284 |
|
|
2020
Q1 | $5.17M | Buy |
82,215
+39,558
| +93% | +$2.85M | 0.03% | 241 |
|
|
2019
Q4 | $3.32M | Sell |
42,657
-36,153
| -46% | -$2.82M | 0.01% | 394 |
|
|
2019
Q3 | $5.78M | Buy |
78,810
+57,681
| +273% | +$4.05M | 0.03% | 277 |
|
|
2019
Q2 | $1.3M | Sell |
21,129
-83,172
| -80% | -$5.03M | 0.01% | 581 |
|
|
2019
Q1 | $6.65M | Buy |
104,301
+61,791
| +145% | +$3.53M | 0.03% | 244 |
|
|
2018
Q4 | $2.17M | Buy |
42,510
+29,700
| +232% | +$1.5M | 0.01% | 421 |
|
|
2018
Q3 | $743K | Sell |
12,810
-68,862
| -84% | -$3.37M | ﹤0.01% | 771 |
|
|
2018
Q2 | $3.96M | Buy |
81,672
+11,487
| +16% | +$536K | 0.02% | 338 |
|
|
2018
Q1 | $3.26M | Buy |
70,185
+64,335
| +1,100% | +$2.79M | 0.01% | 357 |
|
|
2017
Q4 | $220K | Sell |
5,850
-1,209
| -17% | -$44.4K | ﹤0.01% | 739 |
|
|
2017
Q3 | $257K | Sell |
7,059
-27,408
| -80% | -$1.05M | ﹤0.01% | 669 |
|
|
2017
Q2 | $1.36M | Buy |
34,467
+11,451
| +50% | +$418K | 0.01% | 566 |
|
|
2017
Q1 | $722K | Sell |
23,016
-58,218
| -72% | -$1.82M | ﹤0.01% | 656 |
|
|
2016
Q4 | $2.54M | Sell |
81,234
-145,860
| -64% | -$4.73M | 0.01% | 373 |
|
|
2016
Q3 | $9.13M | Buy |
227,094
+109,761
| +94% | +$4.13M | 0.03% | 140 |
|
|
2016
Q2 | $3.9M | Buy |
117,333
+64,569
| +122% | +$2.21M | 0.02% | 216 |
|
|
2016
Q1 | $1.55M | Sell |
52,764
-117,765
| -69% | -$3.25M | 0.01% | 354 |
|
|
2015
Q4 | $4.49M | Buy |
+170,529
| New | +$4.43M | 0.02% | 201 |
|
|
2015
Q1 | – | Sell |
-133,596
| Closed | -$2.84M | – | 845 |
|
|
2014
Q4 | $2.84M | Buy |
+133,596
| New | +$2.68M | 0.01% | 263 |
|
Other funds holding EW
VCM
VPM
CIBC World Market's EW Position: Q1 2026 in Review
CIBC World Market reduced its Edwards Lifesciences (EW) stake by 0.72% in Q1 2026, selling an estimated $19.9K and leaving 33,360 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #699.
CIBC World Market first reported a position in EW in Q4 2014 and has held it in 43 quarters since. The position peaked at $11.7M in Q2 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- CIBC World Market held 33,360 shares of Edwards Lifesciences worth $2.67M as of Q1 2026.
- CIBC World Market sold 241 Edwards Lifesciences shares in Q1 2026, an estimated $19.9K.
- Edwards Lifesciences made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #699 holding.
- CIBC World Market first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 43 quarters since.
- CIBC World Market's Edwards Lifesciences position peaked at $11.7M in Q2 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.